3 recruiting, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 3, Terminated 1 |
Follow Chronic Kidney Disease(CKD): new trials by email Literature Review of Chronic Kidney Disease(CKD) trials Research Report on Chronic Kidney Disease(CKD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients Dapagliflozin (DAPA), Erythropoiesis Stimulating Agent - Chronic Kidney Disease(CKD), Anemia, Kidney Disease, Chronic | Phase 2 | Recruiting | Mansoura University | 80 | 2025-04-01 | 2025-04-02 |
| Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT Finerenone (BAY 94-8862), Empagliflozin 10 mg - Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC) | Phase 2 | Terminated | Jinling Hospital, China | 10 | 2025-01-01 | 2025-12-11 |
| Effect Camostat for Kidney Protection in Chronic Kidney Disease Camostat Mesylate - Chronic Kidney Disease(CKD) | Phase 2 | Recruiting | Odense University Hospital | 40 | 2024-11-21 | 2025-01-27 |
| Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease amiloride, Placebo - Chronic Kidney Disease(CKD), Proteinuria | Phase 2 | Recruiting | Odense University Hospital | 40 | 2024-10-10 | 2025-04-11 |
Renal Insufficiency, Chronic (4) · Proteinuria (2) · Albuminuria (1) · Anemia (1) · Bronchiolitis Obliterans Syndrome (1) · Carcinoma, Renal Cell (1) · Kidney Diseases (1) · Kidney Neoplasms (1)
Chronic Disease (4) · Disease Attributes (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Renal Insufficiency (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Kidney Diseases (3) · Signs and Symptoms (2) · Urination Disorders (2) · Urological Manifestations (2) · Adenocarcinoma (1)
Amiloride (1) · Hematinics (1) · camostat (1) · dapagliflozin (1) · empagliflozin (1) · finerenone (1)
Odense University Hospital (2) · Jinling Hospital, China (1) · Mansoura University (1)
Denmark (2) · China (1) · Egypt (1)
Claus Bistrup, MD, Professor (1) · Noha O. Mansour, Ph.D. (1)
2023 (1)